Stage IV Ovarian Cancer Recruiting Phase 1 Trials for Doxorubicin (DB00997)

IndicationStatusPhase
DBCOND0030167 (Stage IV Ovarian Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01970722Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal CancerTreatment